Bayer Aktiengesellschaft (FRA:BAYN)
34.80
+4.33 (14.19%)
Last updated: Dec 2, 2025, 9:24 AM CET
Bayer Aktiengesellschaft Revenue
Bayer Aktiengesellschaft had revenue of 9.66B EUR in the quarter ending September 30, 2025, a decrease of -3.09%. This brings the company's revenue in the last twelve months to 45.87B, down -1.87% year-over-year. In the year 2024, Bayer Aktiengesellschaft had annual revenue of 46.61B, down -2.16%.
Revenue (ttm)
45.87B
Revenue Growth
-1.87%
P/S Ratio
0.65
Revenue / Employee
518.25K
Employees
91,864
Market Cap
29.93B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 46.61B | -1.03B | -2.16% |
| Dec 31, 2023 | 47.64B | -3.10B | -6.11% |
| Dec 31, 2022 | 50.74B | 6.66B | 15.10% |
| Dec 31, 2021 | 44.08B | 2.68B | 6.48% |
| Dec 31, 2020 | 41.40B | -2.15B | -4.93% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |
Bayer Aktiengesellschaft News
- 10 hours ago - Trump administration backs Bayer's bid to curb Roundup lawsuits - Reuters
- 11 hours ago - Bayer Welcomes Solicitor General Support for U.S. Supreme Court Review - Business Wire
- 18 hours ago - Bayer’s MEDRAD Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations - Wallstreet:Online
- 18 hours ago - Bayer's MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations - Business Wire
- 20 hours ago - Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Value Stock - Nasdaq
- 21 hours ago - Dare Bioscience (DARE) Regains Ovaprene Rights from Bayer - GuruFocus
- 7 days ago - BAYRYs Cardiovascular Drug Hits Goals in Late-Stage Study - Nasdaq
- 7 days ago - Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study - Benzinga